The latest price target for IperionX (NASDAQ: IPX) was reported by Alliance Global Partners on December 8, 2022. The analyst firm set a price target for $16.50 expecting IPX to rise to within 12 months (a possible 70.10% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for IperionX (NASDAQ: IPX) was provided by Alliance Global Partners, and IperionX initiated their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IperionX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IperionX was filed on December 8, 2022 so you should expect the next rating to be made available sometime around December 8, 2023.

While ratings are subjective and will change, the latest IperionX (IPX) rating was a initiated with a price target of $0.00 to $16.50. The current price IperionX (IPX) is trading at is $9.70, which is within the analyst’s predicted range.

The latest price target for IperionX (NASDAQ: IPX) was reported by Alliance Global Partners on December 8, 2022. The analyst firm set a price target for $16.50 expecting IPX to rise to within 12 months (a possible 70.10% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for IperionX (NASDAQ: IPX) was provided by Alliance Global Partners, and IperionX initiated their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IperionX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IperionX was filed on December 8, 2022 so you should expect the next rating to be made available sometime around December 8, 2023.

While ratings are subjective and will change, the latest IperionX (IPX) rating was a initiated with a price target of $0.00 to $16.50. The current price IperionX (IPX) is trading at is $9.70, which is within the analyst’s predicted range.

The latest price target for IperionX (NASDAQ: IPX) was reported by Alliance Global Partners on December 8, 2022. The analyst firm set a price target for $16.50 expecting IPX to rise to within 12 months (a possible 70.10% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for IperionX (NASDAQ: IPX) was provided by Alliance Global Partners, and IperionX initiated their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IperionX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IperionX was filed on December 8, 2022 so you should expect the next rating to be made available sometime around December 8, 2023.

While ratings are subjective and will change, the latest IperionX (IPX) rating was a initiated with a price target of $0.00 to $16.50. The current price IperionX (IPX) is trading at is $9.70, which is within the analyst’s predicted range.

The latest price target for IperionX (NASDAQ: IPX) was reported by Alliance Global Partners on December 8, 2022. The analyst firm set a price target for $16.50 expecting IPX to rise to within 12 months (a possible 70.10% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for IperionX (NASDAQ: IPX) was provided by Alliance Global Partners, and IperionX initiated their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IperionX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IperionX was filed on December 8, 2022 so you should expect the next rating to be made available sometime around December 8, 2023.

While ratings are subjective and will change, the latest IperionX (IPX) rating was a initiated with a price target of $0.00 to $16.50. The current price IperionX (IPX) is trading at is $9.70, which is within the analyst’s predicted range.

The latest price target for IperionX (NASDAQ: IPX) was reported by Alliance Global Partners on December 8, 2022. The analyst firm set a price target for $16.50 expecting IPX to rise to within 12 months (a possible 70.10% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for IperionX (NASDAQ: IPX) was provided by Alliance Global Partners, and IperionX initiated their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IperionX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IperionX was filed on December 8, 2022 so you should expect the next rating to be made available sometime around December 8, 2023.

While ratings are subjective and will change, the latest IperionX (IPX) rating was a initiated with a price target of $0.00 to $16.50. The current price IperionX (IPX) is trading at is $9.70, which is within the analyst’s predicted range.

The latest price target for IperionX (NASDAQ: IPX) was reported by Alliance Global Partners on December 8, 2022. The analyst firm set a price target for $16.50 expecting IPX to rise to within 12 months (a possible 70.10% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for IperionX (NASDAQ: IPX) was provided by Alliance Global Partners, and IperionX initiated their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IperionX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IperionX was filed on December 8, 2022 so you should expect the next rating to be made available sometime around December 8, 2023.

While ratings are subjective and will change, the latest IperionX (IPX) rating was a initiated with a price target of $0.00 to $16.50. The current price IperionX (IPX) is trading at is $9.70, which is within the analyst’s predicted range.

The latest price target for IperionX (NASDAQ: IPX) was reported by Alliance Global Partners on December 8, 2022. The analyst firm set a price target for $16.50 expecting IPX to rise to within 12 months (a possible 70.10% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for IperionX (NASDAQ: IPX) was provided by Alliance Global Partners, and IperionX initiated their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IperionX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IperionX was filed on December 8, 2022 so you should expect the next rating to be made available sometime around December 8, 2023.

While ratings are subjective and will change, the latest IperionX (IPX) rating was a initiated with a price target of $0.00 to $16.50. The current price IperionX (IPX) is trading at is $9.70, which is within the analyst’s predicted range.

The latest price target for IperionX (NASDAQ: IPX) was reported by Alliance Global Partners on December 8, 2022. The analyst firm set a price target for $16.50 expecting IPX to rise to within 12 months (a possible 70.10% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for IperionX (NASDAQ: IPX) was provided by Alliance Global Partners, and IperionX initiated their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IperionX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IperionX was filed on December 8, 2022 so you should expect the next rating to be made available sometime around December 8, 2023.

While ratings are subjective and will change, the latest IperionX (IPX) rating was a initiated with a price target of $0.00 to $16.50. The current price IperionX (IPX) is trading at is $9.70, which is within the analyst’s predicted range.